GlassScriptPrepare for your visit
Swati Ellendula
Carrollton, TX · NPI 1609070325
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,049.31
in general payments reported to CMS, 2019-2025 · $1,273 in 2025
The $1,273 reported for 2025 was more than what 90% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,326.70
- Lundbeck LLC $971.50
- Otsuka America Pharmaceutical, INC. $615.56
- Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $490.93
- Sunovion Pharmaceuticals INC. $393.34
- Tris Pharma INC $380.42
Drugs and devices associated with these payments
Vraylar Rexulti Caplyta Auvelity Azstarys Qelbree Dyanavel Xr Cobenfy Trintellix Uzedy Fanapt Ingrezza
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Swati Ellendula listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/26943/swati-ellendula